Gen Consulting Company predicts the global herg screening market will grow from USD 1,633 million in 2021 to USD 3,043 million by 2028, achieving a compound annual growth rate (CAGR) of 9.3 percent.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global herg screening market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the herg screening industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, ion channel, application, and region. The global market for herg screening can be segmented by type: gene KCNH2, mutant KCNH2. Herg screening market is further segmented by ion channel: ligand-gated ion channels, voltage-gated ion channels, others. Based on application, the herg screening market is segmented into: antiarrhythmic, antibiotics, antipsychotics, others. On the basis of region, the herg screening market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By type:
– gene KCNH2
– mutant KCNH2
By ion channel:
– ligand-gated ion channels
– voltage-gated ion channels
– others
By application:
– antiarrhythmic
– antibiotics
– antipsychotics
– others
By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
The global herg screening market report offers detailed information on several market vendors, including Abcam PLC, Aurora Biomed Inc., B’SYS GmbH, Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, Merck KGaA, Metrion Biosciences Ltd., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global herg screening market.
– To classify and forecast the global herg screening market based on type, ion channel, application, region.
– To identify drivers and challenges for the global herg screening market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global herg screening market.
– To identify and analyze the profile of leading players operating in the global herg screening market.
Why Choose This Report
– Gain a reliable outlook of the global herg screening market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 9.3% |
| Pages | 87 |
| Key Players | Abcam PLC, Aurora Biomed Inc., B'SYS GmbH, Charles River Laboratories International Inc., Creative Bioarray, Eurofins Scientific SE, Merck KGaA, Metrion Biosciences Ltd., Thermo Fisher Scientific Inc. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
